Latest Articles

13. 11. 2020

IMP with GMO for the treatment of COVID in CT 12.11.2020

Information on documentation to be submitted for clinical trials on medicinal products for the treatment of COVID-19, 7.11.2020, updated 12.11.2020

 

04. 11. 2020

Important Information for Applicants for Clinical Trials through the Voluntary Harmonisation Procedure - Brexit and Christmas Break 2020/2021

The State Institute for Drug Control hereby informs the sponsors of clinical trials that  VHP Christmas Break 2020 will be from 22 December 2020 to 6 January 2021.

 

23. 10. 2020

VHP procedures since 23rd October 2020

Important Information for Applicants for Clinical Trials through the Voluntary Harmonisation Procedure

 

30. 09. 2020

List of reimbursed medicinal products valid as of 1.10.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

31. 08. 2020

List of reimbursed medicinal products valid as of 1.9.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List...

 

31. 07. 2020

List of reimbursed medicinal products valid as of 1.8.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

17. 07. 2020

Questions and Answers on the Use of Advanced Therapy Medicinal Products with Out-of-Specification Release Test Results

State Institute for Drug Control issues Questions and Answers document to clarify possibility of administration of advanced therapy medicinal products (ATMPs) in case...